Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Large Decline in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a large decrease in short interest during the month of October. As of October 31st, there was short interest totalling 700 shares, a decrease of 56.3% from the October 15th total of 1,600 shares. Based on an average daily trading volume, of 4,600 shares, the days-to-cover ratio is presently 0.2 days.

Relief Therapeutics Price Performance

Shares of OTCMKTS:RLFTF traded up $0.07 during midday trading on Wednesday, reaching $7.27. The company had a trading volume of 1,274 shares, compared to its average volume of 2,840. The company’s 50 day moving average price is $4.78 and its 200 day moving average price is $2.55. Relief Therapeutics has a 52-week low of $1.10 and a 52-week high of $7.60.

About Relief Therapeutics

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.